GDTC
CytoMed Therapeutics Ltd.
NASDAQ · Healthcare · Biotechnology · SG
$0.85
−3.17%Margins
Gross margin
-82.4%
EBITDA margin
-813.7%
EBIT margin
-775.8%
Net margin
-730.3%
FCF margin
-875.1%
-105.9%
Return on equity
-75.0%
Return on assets
-103.0%
Return on invested capital
0.10x
Asset turnover
-$4.4M
Cash from operations
$0.10
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026